Results 241 to 250 of about 2,689,332 (309)

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Integrative Monitoring of Hypertension Care Using Routinely Collected Clinical Data in Mexico's Emerging Federalised Public Health Care Provider. [PDF]

open access: yesHealth Serv Insights
Silva-Tinoco R   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy